Klogene has its research laboratory in the renowned biotech hub of Boston, but uses primarily a virtual company model. In addition to the strong research ties to Boston University School of Medicine and Universitat Autonoma de Barcelona (e.g. AD, MS and ALS), the company has signed formal collaboration agreements with leading academic and industry research teams active in areas such as cancer, kidney disease and Duchenne Muscular Dystrophy as well as general viral vector research and production required for gene therapy. The company has active programs in small molecules development and gene therapy. Its intellectual property includes direct use of the Klotho protein.
We dare to be first in the pursuit of novel therapeutic strategies, striving to improve the lives of those afflicted by debilitating diseases.
We are excited about our research programs and are passionate about the efforts to take them to the clinic.
We make decisions based on facts, we do what we promise, we execute our plans while being financially conservative.
We show respect to all of our constituents by being ethical, open, honest and fair.